Mizolastine
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | By mouth (tablets) |
ATC code | R06AX25 (WHO) |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
108612-45-9 ![]() |
PubChem (CID) | 65906 |
ChemSpider |
59315 ![]() |
UNII |
244O1F90NA ![]() |
KEGG |
D01117 ![]() |
ChEMBL |
CHEMBL94454 ![]() |
Chemical and physical data | |
Formula | C24H25FN6O |
Molar mass | 432.493 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
![]() ![]() |
Mizolastine (Mizollen) is a once-daily, non-sedating antihistamine. It blocks H1 receptors and is commonly fast-acting. It does not prevent the actual release of histamine from mast cells, just prevents it binding to receptors. Side effects can include dry mouth and throat.[1]
References
- ↑ "MIZOLASTINE: British National Formulary". Retrieved 2010-02-01.
This article is issued from Wikipedia - version of the 10/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.